CompletedNot Applicable

Ocular Manifestations in Rheumatic Diseases

5,000 participantsStarted 2013-05-01

Plain-language summary

This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in inflammatory rheumatic disease Exclusion Criteria: * review articles, * case reports where all patients experienced the same ocular comorbidity * if different comorbidities were not grouped independently * if the study reported on fewer than 20 patients

What they're measuring

Prevalence of ocular manifestations of inflammatory rheumatic diseases

Timeframe: data is collected once per year up to 2020

Trial details

NCT IDNCT03753893

SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-01

View on ClinicalTrials.gov More Uveitis trials